Multiscale benchmarking of drug delivery vectors

Langer, 1998, Drug delivery and targeting, Nature, 392, 5 Byers, 2009, Pharmacokinetic modeling, Pharmacology, 201, 10.1016/B978-0-12-369521-5.00010-5 Allen, 2004, Drug delivery systems: entering the mainstream, Science, 303, 1818, 10.1126/science.1095833 Faraji, 2009, Nanoparticles in cellular drug delivery, Bioorg Med Chem, 17, 2950, 10.1016/j.bmc.2009.02.043 Tasciotti, 2008, Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications, Nat Nanotechnol, 3, 151, 10.1038/nnano.2008.34 Davis, 2008, Nanoparticle therapeutics: an emerging treatment modality for cancer, Nat Rev Drug Discov, 7, 771, 10.1038/nrd2614 Ferrari, 2005, Cancer nanotechnology: opportunities and challenges, Nat Rev Cancer, 5, 161, 10.1038/nrc1566 McNeil, 2009, Nanoparticle therapeutics: a personal perspective, Wiley Interdiscip Rev Nanomed Nanobiotechnol, 1, 264, 10.1002/wnan.6 Otto, 2014, Differences in physicochemical properties to consider in the design, evaluation and choice between microparticles and nanoparticles for drug delivery, Expert Opin Drug Deliv, 1 Doak, 2009, Confounding experimental considerations in nanogenotoxicology, Mutagenesis, 24, 285, 10.1093/mutage/gep010 Soenen, 2011, Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation, Nano Today, 6, 446, 10.1016/j.nantod.2011.08.001 Oberdörster, 2010, Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology, J Intern Med, 267, 89, 10.1111/j.1365-2796.2009.02187.x Kroll, 2011, Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays, Part Fibre Toxicol, 8, 9, 10.1186/1743-8977-8-9 Sohaebuddin, 2010, Nanomaterial cytotoxicity is composition, size, and cell type dependent, Part Fibre Toxicol, 7, 22, 10.1186/1743-8977-7-22 Carlson, 2008, Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species, J Phys Chem B, 112, 13608, 10.1021/jp712087m Kim, 2012, Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population, Nat Nanotechnol, 7, 62, 10.1038/nnano.2011.191 Di Marco, 2010, Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation, Int J Nanomedicine, 5, 37 Steinbacher, 2014, Adsorption and release of siRNA from porous silica, Langmuir, 30, 4396, 10.1021/la402850m He, 2012, Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs, Biomaterials, 33, 8569, 10.1016/j.biomaterials.2012.07.063 Hwu, 2009, Targeted Paclitaxel by conjugation to iron oxide and gold nanoparticles, J Am Chem Soc, 131, 66, 10.1021/ja804947u Xu, 2005, In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery, Int J Pharm, 288, 361, 10.1016/j.ijpharm.2004.10.009 Gurunathan, 2013, Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells, Biomed Res Int, 2013, 535796, 10.1155/2013/535796 Ivask, 2014, Size-dependent toxicity of silver nanoparticles to bacteria, yeast, algae, crustaceans and mammalian cells in vitro, PLoS One, 9, e102108, 10.1371/journal.pone.0102108 Chakravarthi, 2010, Comparison of anti-tumor efficacy of paclitaxel delivered in nano- and microparticles, Int J Pharm, 383, 37, 10.1016/j.ijpharm.2009.09.004 Barbé, 2004, Silica particles: a novel drug-delivery system, Adv Mater, 16, 1959, 10.1002/adma.200400771 Kataoka, 2001, Block copolymer micelles for drug delivery: design, characterization and biological significance, Adv Drug Deliv Rev, 47, 113, 10.1016/S0169-409X(00)00124-1 Agnihotri, 2004, Recent advances on chitosan-based micro- and nanoparticles in drug delivery, J Control Release, 100, 5, 10.1016/j.jconrel.2004.08.010 Bianco, 2005, Applications of carbon nanotubes in drug delivery, Curr Opin Chem Biol, 9, 674, 10.1016/j.cbpa.2005.10.005 Rosenholm, 2010, Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors, Small, 6, 1234, 10.1002/smll.200902355 Dobson, 2006, Magnetic micro- and nano-particle-based targeting for drug and gene delivery, Nanomedicine (Lond), 1, 31, 10.2217/17435889.1.1.31 Moghimi, 2012, Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective, Annu Rev Pharmacol Toxicol, 52, 481, 10.1146/annurev-pharmtox-010611-134623 Limbach, 2005, Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations, Environ Sci Technol, 39, 9370, 10.1021/es051043o Florez, 2012, How shape influences uptake: interactions of anisotropic polymer nanoparticles and human mesenchymal stem cells, Small, 8, 2222, 10.1002/smll.201102002 Champion, 2007, Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers, J Control Release, 121, 3, 10.1016/j.jconrel.2007.03.022 Whitesides, 2003, The “right” size in nanobiotechnology, Nat Biotechnol, 21, 1161, 10.1038/nbt872 Basu, 2007, Biomolecule induced nanoparticle aggregation: effect of particle size on interparticle coupling, J Colloid Interface Sci, 313, 724, 10.1016/j.jcis.2007.04.069 Walkey, 2012, Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake, J Am Chem Soc, 134, 2139, 10.1021/ja2084338 Chithrani, 2006, Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells, Nano Lett, 6, 662, 10.1021/nl052396o Lison, 2008, Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays, Toxicol Sci, 104, 155, 10.1093/toxsci/kfn072 Teeguarden, 2007, Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments, Toxicol Sci, 95, 300, 10.1093/toxsci/kfl165 Wittmaack, 2011, Novel dose metric for apparent cytotoxicity effects generated by in vitro cell exposure to silica nanoparticles, Chem Res Toxicol, 24, 150, 10.1021/tx100331w Ware, 2014, Analysis of the influence of cell heterogeneity on nanoparticle dose response, ACS Nano, 8, 6693, 10.1021/nn502356f Mecke, 2005, Lipid bilayer disruption by polycationic polymers: the roles of size and chemical functional group, Langmuir, 21, 10348, 10.1021/la050629l Romoser, 2011, Mitigation of quantum dot cytotoxicity by microencapsulation, PLoS One, 6, 1, 10.1371/journal.pone.0022079 BLISS, 2008, The calculation of the time-mortality curve, Ann Appl Biol, 24, 815, 10.1111/j.1744-7348.1937.tb05058.x Hinderliter, 2010, ISDD: a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies, Part Fibre Toxicol, 7, 36, 10.1186/1743-8977-7-36 Erickson, 2009, Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy, Biol Proced Online, 11, 32, 10.1007/s12575-009-9008-x Gaylor, 2000, The use of Haber’s Law in standard setting and risk assessment, Toxicology, 149, 17, 10.1016/S0300-483X(00)00228-6